Lenalidomide 25mg | Brand: Revlimid | 📷 medshopy.com/blood-cancer-medicine.html
Princess Margaret Cancer Centre in Toronto — one of the world's top-ranked cancer hospitals — manages multiple myeloma patients from across Ontario and beyond. Following Revlimid patent expiry, Lenalid 25mg provides Toronto myeloma patients with the same IMiD therapy backbone at dramatically reduced cost, making long-term maintenance therapy financially sustainable.
Toronto's large South Asian, East Asian, and Caribbean communities — all with specific myeloma incidence patterns — access Princess Margaret's world-class haematology services. For patients in coverage gaps, waiting for ODB approval, or funding their own treatment, generic Lenalid delivers the same clinical outcomes that have made Lenalidomide a cornerstone of modern myeloma management.
Visit medshopy.com or WhatsApp +91 82650 41513 for Toronto and Ontario supply.
❓ What is smouldering myeloma and is Lenalid used for it?
Smouldering multiple myeloma (SMM) is a precursor condition to active myeloma — patients have abnormal plasma cells and elevated M-protein but no organ damage or symptoms from the disease. Historically treated with watchful waiting, recent clinical trials have shown early treatment of high-risk SMM with Lenalidomide can delay or prevent progression to active myeloma requiring intensive chemotherapy. The ECOG E3A06 trial demonstrated significantly longer progression-free survival with Lenalidomide treatment in high-risk SMM. Toronto's Princess Margaret haematologists actively monitor SMM patients for progression risk factors and discuss early intervention options, though this remains an evolving area with ongoing trials refining which SMM patients benefit most from early treatment.
